Evidence map›Paper›PMID 26060725›Full record

ArticleIranian journal of public health2014

Frequency of Human Papillumavirus among Women with High-Grade Squamous Intraepithelial Lesions and Invasive Cervical Cancer Attending Shahid Beheshti University of Medical Sciences Clinics, Tehran, Iran.

Nahid Khodakarami, Afshin Moradi, Hamidreza Mirzaei, Farah Farzaneh, Parvin Yavari, Mohamad Esmaeil Akbari

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nahid Khodakarami1. Cancer Research Center, Shahid Beheshti University of Medical Sciences , Tehran, Iran.
Afshin Moradi2. Dept. of Pathology, Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences , Tehran, Iran.
Hamidreza Mirzaei3. Dept. of Oncology, Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences , Tehran, Iran.
Farah Farzaneh4. Dept. of Obstetrics/Gynecology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences , Tehran, Iran.
Parvin Yavari5. Dept., of Epidemiology, Health & Community Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences , Tehran, Iran.
Mohamad Esmaeil Akbari1. Cancer Research Center, Shahid Beheshti University of Medical Sciences , Tehran, Iran.
Shahid Beheshti University of Medical Sciences · IRImam Hossein Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe previous studies reported some information about prevalence release of high-risk HPV types in HSIL or cervical cancer globally and in Iran, however, this information is not enough for final judgment about vaccination against HPV or any screening program. The aim of the present study was to assess the HPV type distribution in HSIL and ICC specimens of women attending Shahid Beheshti University of Medical Sciences teaching hospitals, Tehran, Iran for treatment during 10 years.

methodsThis retrospective- descriptive study evaluated the HPV type distribution of pathologic specimens of Iranian women with invasive cervical cancer (ICC) and high-grade squamous cell intraepithelial lesions (HSIL). Formalin-fixed tumor biopsies that were retrieved from women presenting with histological confirmation for ICC and 17 pathologic confirmation for HSIL specimens.

resultsThe most frequently identified HPV type 16 among both groups, women with invasive cervical cancer (4-2.18%) and women with High Grade Squamous Intraepithelial Lesion (29.41%), followed by HPV18, HPV31 and 26. HPV16 and / or 18 accounted for 82.2% of all infected samples.

conclusionThe dominance of HPV16 over other high-risk types might be even higher than in a region with low HPV exposure. However, there was no strong evidence for any judgment that show to the policy makers; which one is cost-effectiveness and feasibility for cervical cancer prevention in Iran, vaccination, screening or both? More population based study and national meta-analysis needed for better understanding of HPV prevalence and HPV DNA patterns in Iran.

Indexed as

Human papillomavirusInvasive cervical cancerIranSquamous intraepithelial lesions

Identifiers

PMID26060725
PMCPMC4449507
OpenAlexW2097907945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.